AI startup Recursive Superintelligence has signed on to lease $410 million in compute from Amazon Web Services (AWS).

Richard Socher's Recursive put about two-thirds of its $650m raise into one multi-year AWS compute deal, and calls it the smallest it will sign.

Evidence that AI-fueled drug discovery is the way forward is hard to find now, but that could change in 2025. After merging with Exscientia, Recursion will have 10 clinical readouts to look forward to ...

AndroGuider is a blog where you can scoop your daily need of tech information with some dose of special reviews and custom ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...

Recursion said today it is eliminating approximately 20% of its workforce—about 160 jobs—in a restructuring the AI-based drug developer said reflects both its recently-pruned pipeline and the ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Recursion in Java gets a bad rap. Experienced developers shun the practice over fears that an ...